Mani Naghibi

St. Mark's Hospital
Consultant Gastroenterologist at St. Mark''s Hospital

Dr Mani Naghibi gained his medical degree at Guy’s Kings and St Thomas’ School of Medicine in London, where he also undertook a second intercalated degree in Anatomy and Physiology. While at University he carried out research in the topic of drug delivery to the brain. After university he completed his medical training in the London and Wessex deaneries, specialising in Gastroenterology and General Internal Medicine.

Mani undertook his sub-speciality training and research at University Hospital Southampton (UHS), supported by the National Institute of Health Research (NIHR) Biomedical Research Centre for Nutrition. His Medical Doctorate (MD) thesis was based on the use of artificial nutrition for patients with nutrition failure in the context of cancer. He has presented the results of this and other research topics at national and international conferences as well as at invited lectures.

Working with the Inflammatory Bowel Disease team at UHS, Mani was awarded the Shire Prize in innovation in Gastroenterology in 2014 for designing and implementing a web-based patient management system, which allows patients to take greater control of their health and medical treatments.

His clinical interests are supplemental and artificial nutrition, inflammatory bowel conditions, gastrointestinal endoscopy, functional bowel disorders and effects of medical treatments on quality of life. He continues his research interests into the effects of artificial nutrition in both cancer and non-cancer patients.

Before commencing his Consultant post at St Mark’s Hospital, Mani was the Specialist Registrar trainee representative for the British Society of Gastroenterology (BSG) Small Bowel and Nutrition committee, as well as the British Association for Parenteral and Enteral Nutrition (BAPEN). He is currently a committee member for the British Artificial Nutrition Survey (BANS).

dont miss

Eat your way to prevention, and improved treatment outcomes

Parenteral nutrition uses the intravenous route to maintain fluid and nutrient intake when the use of the gastrointestinal tract has become ineffective or inaccessible. This treatment can be provided at home and used long-term.
If intestinal failure occurs in the context of incurable malignancy the main cause of mortality and morbidity will be dehydration and malnutrition, rather than the direct effects of the underlying malignant process.
This seminar will review the evidence for life expectancy, quality of life, optimal patient selection and the health economics of home parenteral nutrition in this clinical context.

EVEN MORE SEMINARS

  • Mylaine Riobe MD, FABOIM, FACOG: Speaking at the Oncology Convention

    Mylaine Riobe MD, FABOIM, FACOG
    Riobe Institute of Integrative Medicine

    Cancer is not random! Evolving mechanisms for cancer causation and prevention

  • Imran Liaquat MBChB BSc MedSci MRCS FRCS MEd: Speaking at the Oncology Convention

    Imran Liaquat MBChB BSc MedSci MRCS FRCS MEd
    NHS Lothian, Scotland

    Optimising Surgical Resection in Low Grade Glioma Patients

  • Sanjay P Prabhu: Speaking at the Oncology Convention

    Sanjay P Prabhu
    Boston Children’s Hospital & Harvard Medical School

    Evolving role of machine learning in brain tumour imaging

  • Professor Alex Mirnezami: Speaking at the Oncology Convention

    Professor Alex Mirnezami
    University of Southampton

    Biomarkers of Epithelial to Mesenchymal Transition and their clinical relevance in colorectal cancer

  • Dr Ndaba Mazibuko: Speaking at the Oncology Convention

    Dr Ndaba Mazibuko
    Care Oncology Clinic, Kings College London

    Drug Repurposing In Practice: Metabolic Pleiotropism in Glioblastoma Management